Pyxis Oncology, Inc. Common Stock (NASDAQ: PYXS) last traded at $3.08, down 1.28% on the session. The quote above updates while this page is open; the figures below are drawn from Pyxis Oncology, Inc. Common Stock’s own filings and are restated only when a new one is published.
Pyxis Oncology, Inc. Common Stock trades on NASDAQ under the ticker PYXS. Its market capitalisation is $256.90 million.
Valuation measures for Pyxis Oncology, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $256.90M |
|---|---|
| Enterprise value | $281.52M |
| Price / sales | 18.54 |
| Price / book | 22.46 |
| Beta | 1.24 |
Trailing-twelve-month figures tagged in Pyxis Oncology, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $13.86M |
|---|---|
| Net income (TTM) | -$88.73M |
| EPS (TTM) | -$1.40 |
| Operating margin | -664.64% |
| Return on equity | -775.59% |
| Cash | $18.86M |
Range and volume for PYXS over the past 52 weeks.
| 52-week high | $5.55 |
|---|---|
| 52-week low | $1.03 |
| Volume | 658.3K |
| Average volume | 1.20M |
| Previous close | $3.12 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.